Evonik stock: report due November 3, 2026, little changed pre-market
Published on 10/21/2026 at 09:00 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSQuarterly reporting ahead
- The quarterly report is scheduled for November 3, 2026.
- The investor-relations calendar lists one online, on-demand event.
- Evonik stock trades pre-market at EUR 20.88 at 8:58 a.m. CEST at Lang & Schwarz on October 21, 2026, 0.29 percent below the Xetra close of October 20, 2026.
Evonik's investor-relations calendar lists its third-quarter 2026 report for November 3, 2026. The entry is identified as an online, on-demand event by Evonik investor relations. Evonik stock trades pre-market at EUR 20.88 at 8:58 a.m. CEST at Lang & Schwarz on October 21, 2026, 0.29 percent below the Xetra close of October 20, 2026 (EUR 20.94).
The next company date
The November 3 report will cover Evonik's business development in the third quarter of 2026, according to the investor-relations calendar. Evonik lists the event as online and on demand.
Before the Xetra open
The pre-market indication is EUR 0.06 below the Xetra reference level. The further course from the Xetra open at 9:00 a.m. CET/CEST is shown by the continuously updated real-time quote of Evonik stock.
Evonik's operating focus
Evonik develops and produces lipid-based drug-delivery solutions for pharmaceutical and biotech customers. The investor-relations calendar places the next company report on November 3, 2026, and identifies it as an online, on-demand event.
Market context: Market report DAX.
